JULIE THOMISON: Open Payments
NPI 1275092959 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 34 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $247 |
| ARGENX US, INC. | 2 | $60 |
| Genentech USA, Inc. | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| SK Life Science, Inc. | 2 | $50 |
| Amneal Pharmaceuticals LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| ACADIA Pharmaceuticals Inc | 2 | $34 |
| Eisai Inc. | 1 | $31 |
| UCB, Inc. | 1 | $30 |
Products named: QULIPTA, UBRELVY, Ocrevus Zunovo, AUSTEDO XR, CREXONT, KESIMPTA, VYVGART HYTRULO, Leqembi.
Industry payments across TX — which companies pay providers there.
